sb 211475 has been researched along with adenosine diphosphate in 1 studies
| Studies (sb 211475) | Trials (sb 211475) | Recent Studies (post-2010) (sb 211475) | Studies (adenosine diphosphate) | Trials (adenosine diphosphate) | Recent Studies (post-2010) (adenosine diphosphate) |
|---|---|---|---|---|---|
| 6 | 0 | 1 | 23,989 | 498 | 3,114 |
| Protein | Taxonomy | sb 211475 (IC50) | adenosine diphosphate (IC50) |
|---|---|---|---|
| Chain A, Kinesin-like protein KIF11 | Homo sapiens (human) | 0.45 | |
| Heat shock 70 kDa protein 1A | Homo sapiens (human) | 0.5 | |
| Sensor protein kinase WalK | Staphylococcus aureus | 7.189 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feuerstein, GZ; Gu, JL; Lysko, KA; Lysko, PG; Mckenna, PJ; Ruffolo, RR; Yue, TL | 1 |
1 other study(ies) available for sb 211475 and adenosine diphosphate
| Article | Year |
|---|---|
SB 211475, a metabolite of carvedilol, a novel antihypertensive agent, is a potent antioxidant.
Topics: Adenosine Diphosphate; Animals; Antihypertensive Agents; Antioxidants; Ascorbic Acid; Brain; Carbazoles; Cattle; Cell Death; Cells, Cultured; Chromans; Endothelium, Vascular; Fumarates; Humans; Iron; Lipid Peroxidation; Lipoproteins, LDL; Macrophages; Male; Mice; Neurons; Neutrophils; Nicardipine; Oxidation-Reduction; Piperazines; Propanolamines; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Superoxides; Tetradecanoylphorbol Acetate; Xanthine; Xanthine Oxidase; Xanthines | 1994 |